Skip to content

Cost-effectiveness of an early Cognitive Behavioral Treatment in work disability due to musculoskeletal disorders

Cost-effectiveness of an early Cognitive Behavioral Treatment in work disability due to musculoskeletal disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17984927
Enrollment
200
Registered
2007-06-27
Start date
2004-10-15
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal disorders-related temporary work disability Musculoskeletal Diseases work disability

Interventions

A psychologist will deliver CBT that is complementary to a rheumatologic specific program. One session lasts 45 minutes. The number of sessions is not previously fixed, and varies between 1 and a maxi

Sponsors

Musculoskeletal Disease Foundation and FREMAP Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Musculoskeletal disorders-related temporary work disability for at least 3 weeks 2. Admitted to the rheumatologic specialized care

Exclusion criteria

Exclusion criteria: Patients with more than 8 weeks MSD-related temporary work disability.

Design outcomes

Primary

MeasureTime frame
Efficacy was defined as the differences between groups in the following (assessed for each participant 6 months after inclusion into the study): 1. Duration of all MSD-TWD episodes 2. Number of MSD-TWD episodes per patient 3. Number or relapses of MSD-TWD episodes 4. Duration or relapses of MSD-TWD episodes 5. Number and outcome of proposal for permanent work disability

Secondary

MeasureTime frame
Cost measures

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026